UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000014351
Receipt number R000016703
Scientific Title Phase II Neoadjuvant Study of EC followed by Abraxane in opetable breast cancer.
Date of disclosure of the study information 2014/06/24
Last modified on 2018/11/19 15:34:39

No. Disposal Last modified on Item of update
1 Insert 2014/06/23 16:13:18
2 Update 2016/02/19 11:05:20 Recruitment status
3 Update 2016/02/19 11:09:16 Organization
Organization
Category of Funding Organization
4 Update 2016/11/07 09:22:57 Name of primary person or sponsor
Organization
5 Update 2018/11/19 15:34:39 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded